These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31267952)

  • 1. [Bilateral atypical femoral fractures after prolonged antiresorptive treatment].
    Solis AMB; Hitz MF; Jensen JB
    Ugeskr Laeger; 2019 Jun; 181(24):. PubMed ID: 31267952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the incidence of atypical femoral fractures and bisphosphonate therapy.
    Clout A; Narayanasamy N; Harris I
    J Orthop Surg (Hong Kong); 2016 Apr; 24(1):36-40. PubMed ID: 27122510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical femoral fracture in a bisphosphonate-naïve patient on denosumab for osteoporosis.
    Kumar S; Chang R; Reyes M; Diamond T
    Arch Osteoporos; 2022 Oct; 17(1):131. PubMed ID: 36180610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.
    Starr J; Tay YKD; Shane E
    Curr Osteoporos Rep; 2018 Aug; 16(4):519-529. PubMed ID: 29951870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.
    Dell R; Greene D
    Osteoporos Int; 2018 Jun; 29(6):1277-1283. PubMed ID: 29675745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry.
    Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC
    J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lateral Cortical Thickening and Bone Heterogeneity of the Subtrochanteric Femur Measured With Quantitative CT as Indicators for Early Detection of Atypical Femoral Fractures in Long-Term Bisphosphonate Users.
    Lee SH; Lee YH; Suh JS
    AJR Am J Roentgenol; 2017 Oct; 209(4):867-873. PubMed ID: 28796551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium.
    Lee JK
    Int J Rheum Dis; 2009 Jul; 12(2):149-54. PubMed ID: 20374333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MANAGEMENT OF ENDOCRINE DISEASE: Atypical femoral fractures: risks and benefits of long-term treatment of osteoporosis with anti-resorptive therapy.
    Adler RA
    Eur J Endocrinol; 2018 Mar; 178(3):R81-R87. PubMed ID: 29339529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral femur fractures associated with short-term bisphosphonate use.
    Rifai A; Pourtaheri S; Carbone A; Callaghan JJ; Stadler CM; Record N; Issa K
    Orthopedics; 2015 Feb; 38(2):e139-42. PubMed ID: 25665120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical femoral fracture, case report and literature review.
    Cleto-Zepeda G; Durán-Martínez N; Tena-Sanabria ME
    Acta Ortop Mex; 2019; 33(1):39-41. PubMed ID: 31480125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral atypical femur fractures without bisphosphonate exposure.
    Szolomayer LK; Ibe IK; Lindskog DM
    Skeletal Radiol; 2017 Feb; 46(2):241-247. PubMed ID: 27900455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive bilateral femoral nailing in atypical femoral fracture non responder to anabolic therapy: case report and mini-review.
    Neri E; Gabriele L; Bottai V; Andreani L; Bonicoli E; Scaglione M
    Acta Biomed; 2022 Jan; 92(S1):e2021130. PubMed ID: 35049529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative treatment of recurrent symptoms of an incomplete, atypical femoral fracture associated with glucocorticoid, bisphosphonate, and denosumab therapy in a patient with chronic obstructive pulmonary disease.
    Lai KH; Chiang CY; Yang RS; Yang KC; Wu CC
    Acta Clin Belg; 2019 Oct; 74(5):370-374. PubMed ID: 30336748
    [No Abstract]   [Full Text] [Related]  

  • 15. Atypical Femoral Fractures Can Happen Even With Short Duration Bisphosphonate Treatment.
    Kohli R; Siva C
    Conn Med; 2015 Aug; 79(7):419-22. PubMed ID: 26411180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use.
    Weil YA; Rivkin G; Safran O; Liebergall M; Foldes AJ
    J Trauma; 2011 Jul; 71(1):186-90. PubMed ID: 21610533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Koh JH; Myong JP; Yoo J; Lim YW; Lee J; Kwok SK; Park SH; Ju JH
    Osteoporos Int; 2017 Nov; 28(11):3251-3259. PubMed ID: 28748389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy.
    Franceschetti P; Bondanelli M; Caruso G; Ambrosio MR; Lorusso V; Zatelli MC; Massari L; Degli Uberti EC
    Bone; 2013 Oct; 56(2):426-31. PubMed ID: 23871850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATYPICAL FEMORAL FRACTURES AFTER LONG-TERM BISPHOSPHONATES THERAPY: CASE REPORT.
    Găleşanu C; Mocanu V; Buzdugă C; Florescu A; Zaharia V; Lisnic V
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):114-8. PubMed ID: 27125082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiresorptive Therapies for Osteoporosis.
    Weinerman S; Usera GL
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):555-60. PubMed ID: 26412797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.